Literature DB >> 6973431

Role of adenosine deaminase in the early stages of precursor T cell maturation.

A Shore, H M Dosch, E W Gelfand.   

Abstract

The role of adenosine deaminase in the initial stages of precursor T cell differentiation was examined in patients with adenosine deaminase deficiency. Incubation of precursor T cells from adenosine deaminase-deficient patients directly in contact with thymic epithelial monolayers induced receptors for sheep erythrocytes (E rosettes). Pretreatment of these monolayers with erythro-9-(2-hydroxy-3-nonyl) adenine, an inhibitor of adenosine deaminase, prevented differentiation only of adenosine deaminase-deficient T cell precursors, and this could be restored by providing adenosine deaminase following the incubation with thymic epithelial cells. These studies indicate a role for adenosine deaminase in the earliest stages of T cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973431      PMCID: PMC1537208     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Differentiation of thymocytes: evidence that induction of the surface phenotype requires transcription and translation.

Authors:  B Storrie; G Goldstein; E A Boyse; U Hammerling
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

Review 2.  Metabolic aspects of immunodeficiency disease.

Authors:  S H Polmar
Journal:  Semin Hematol       Date:  1980-01       Impact factor: 3.851

3.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

4.  Demonstration of an intrathymic defect in a case of severe combined immunodeficiency disease.

Authors:  K W Pyke; H Dosch; M M Ipp; E W Gelfand
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

5.  Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  M S Coleman; J Donofrio; J J Hutton; L Hahn; A Daoud; B Lampkin; J Dyminski
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

6.  Severe combined immunodeficiency and adenosine deaminase deficiency.

Authors:  R Parkman; E W Gelfand; F S Rosen; A Sanderson; R Hirschhorn
Journal:  N Engl J Med       Date:  1975-04-03       Impact factor: 91.245

7.  Detection of T-precursor cells in human bone marrow and foetal liver.

Authors:  K W Pyke; E W Gelfand
Journal:  Differentiation       Date:  1976-06-04       Impact factor: 3.880

8.  Selective toxicity of purine deoxynucleosides for human lymphocyte growth and function.

Authors:  E W Gelfand; J J Lee; H M Dosch
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

9.  Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.

Authors:  A Cohen; R Hirschhorn; S D Horowitz; A Rubinstein; S H Polmar; R Hong; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

10.  Inhibition of maturation of human precursor lymphocytes by coformycin, an inhibitor of the enzyme adenosine deaminase.

Authors:  J J Ballet; R Insel; E Merler; F S Rosen
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  9 in total

1.  Lymphocytic adenosine deaminase activity in typhoid fevers.

Authors:  S N Khosla; D Kumar; V Singh
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

2.  Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.

Authors:  A D Webster; H Ip; S Pereira
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

3.  Expression of human adenosine deaminase using a transmissable murine retrovirus vector system.

Authors:  R L Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

4.  Adenosine deaminase activity in the diagnosis of tuberculous peritonitis.

Authors:  J M Martinez-Vazquez; I Ocaña; E Ribera; R M Segura; C Pascual
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

5.  Serum adenosine deaminase activity in brain tumours.

Authors:  S Manjula; A Raja; S N Rao; A R Aroor; A Rao
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

6.  Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.

Authors:  H Yuksel; T F Akoğlu
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

7.  Deficits in endogenous adenosine formation by ecto-5'-nucleotidase/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis.

Authors:  Laura Oliveira; Alexandra Correia; Ana Cristina Costa; Sónia Guerra-Gomes; Fátima Ferreirinha; Maria Teresa Magalhães-Cardoso; Manuel Vilanova; Paulo Correia-de-Sá
Journal:  Mediators Inflamm       Date:  2015-01-27       Impact factor: 4.711

8.  Adenosine Deaminase as a Biomarker of Tenofovir Mediated Inflammation in Naïve HIV Patients.

Authors:  Francisco Miguel Conesa-Buendía; Patricia Llamas-Granda; Patricia Atencio; Alfonso Cabello; Miguel Górgolas; Raquel Largo; Gabriel Herrero-Beaumont; Aránzazu Mediero
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

9.  The Use of Induced Pluripotent Stem Cells to Study the Effects of Adenosine Deaminase Deficiency on Human Neutrophil Development.

Authors:  Michael Tsui; Weixian Min; Stephanie Ng; Kerry Dobbs; Luigi D Notarangelo; Yigal Dror; Eyal Grunebaum
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.